Researchers used advanced imaging to uncover early molecular changes in bone that may enable earlier diagnosis of ...

How HRD and BRCA results steer frontline ovarian cancer maintenance—niraparib vs olaparib—plus guidance on recurrence, ...

NSCLC remains the leading cause of cancer-related mortality worldwide, with EGFR mutations being a critical driver in approximately 10-15% of lung adenocarcinomas in Western populations, and up to 40% ...

Molecular glues offer transformative solutions for complex diseases, targeting previously “undruggable” proteins. Key opportunities include their application in oncology, CNS disorders, and precision ...

New research reveals the cellular secrets of aging, with cutting-edge single-cell data mapping how neurons, glial cells, and immune systems reshape the aging brain. Study: Brain-wide ...

BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...

Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...

Potential therapeutic implications of next generation sequencing (NGS)-based molecular profiling in HR+/HER2- metastatic breast cancer (mBC). Differences in treatment outcomes in relation to level of ...

mFAST-SeqS based aneuploidy score in circulating cell-free DNA and role as early response marker in patients with metastatic prostate cancer treated with androgen receptor signaling inhibitor. The ...

Osteoarthritis often goes undetected until cartilage damage is advanced, limiting treatment options. A new study shows that molecular changes in subchondral bone occur earlier and can signal disease ...